EP1012266A4 - Galectine 8, 9, 10, et 10sv - Google Patents
Galectine 8, 9, 10, et 10svInfo
- Publication number
- EP1012266A4 EP1012266A4 EP97912689A EP97912689A EP1012266A4 EP 1012266 A4 EP1012266 A4 EP 1012266A4 EP 97912689 A EP97912689 A EP 97912689A EP 97912689 A EP97912689 A EP 97912689A EP 1012266 A4 EP1012266 A4 EP 1012266A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- galectin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4726—Lectins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4724—Lectins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2809396P | 1996-10-09 | 1996-10-09 | |
WOPCT/US96/16565 | 1996-10-09 | ||
US28093P | 1996-10-09 | ||
US9616565 | 1996-10-09 | ||
PCT/US1997/018261 WO1998015624A1 (fr) | 1996-10-09 | 1997-10-09 | Galectine 8, 9, 10, et 10sv |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1012266A1 EP1012266A1 (fr) | 2000-06-28 |
EP1012266A4 true EP1012266A4 (fr) | 2004-04-28 |
Family
ID=26703285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP97912689A Withdrawn EP1012266A4 (fr) | 1996-10-09 | 1997-10-09 | Galectine 8, 9, 10, et 10sv |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1012266A4 (fr) |
JP (1) | JP2001501831A (fr) |
CA (1) | CA2268022A1 (fr) |
WO (1) | WO1998015624A1 (fr) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999062556A1 (fr) * | 1998-06-03 | 1999-12-09 | Effector Cell Institute | Facteur chimiotactique pour les eosinophiles |
CN1302881A (zh) * | 1999-10-28 | 2001-07-11 | 上海博容基因开发有限公司 | 一种新的多肽——人β-半乳糖苷结合蛋白和编码这种多肽的多核苷酸 |
US6953658B2 (en) | 2000-03-09 | 2005-10-11 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer |
CN1306271C (zh) * | 2000-11-01 | 2007-03-21 | 株式会社嘉尔药物 | 癌转移能力检测剂 |
EP1490403A2 (fr) * | 2002-02-28 | 2004-12-29 | YEDA RESEARCH AND DEVELOPMENT Co. LTD. | Agents de liaison de glycoproteines cd44 et methodes d'utilisation associees |
WO2003074673A2 (fr) * | 2002-03-01 | 2003-09-12 | Exelixis, Inc. | Lgals tenant lieu de modificateurs de la voie de chk et leurs procedes d'utilisation |
CA2505931A1 (fr) * | 2002-11-14 | 2004-05-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Nouvelles sequences de galectine, et compositions et methodes utilisant celles-ci pour traiter ou diagnostiquer l'arthrite et d'autres maladies inflammatoires chroniques |
US20060009378A1 (en) | 2002-11-14 | 2006-01-12 | Itshak Golan | Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
CA2514108A1 (fr) * | 2003-01-24 | 2004-08-05 | Galpharma Co., Ltd. | Medicaments contenant galectine 9 |
EP1619203A1 (fr) * | 2003-04-28 | 2006-01-25 | Galpharma Co., Ltd. | Facteur d'induction de la galectine 9 |
DE10333406A1 (de) * | 2003-07-15 | 2005-02-10 | Protagen Ag | T-regulatorische-Zellen enthaltend Galectine zur Therapie und Diagnose von Erkrankungen |
EP1685159B1 (fr) * | 2003-10-03 | 2012-08-01 | Brigham & Women's Hospital | Polypeptides de Tim-3 |
TW200539890A (en) | 2004-03-12 | 2005-12-16 | Brigham & Womens Hospital | Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
DK1736541T3 (da) * | 2004-03-29 | 2013-05-06 | Galpharma Co Ltd | Nyt modificeret galectin 9-protein og anvendelse heraf |
WO2005121340A1 (fr) * | 2004-06-14 | 2005-12-22 | Galpharma Co., Ltd. | Nouvelle protéine de modification galectine 8 et utilisation de celle-ci |
CN1332030C (zh) * | 2005-04-28 | 2007-08-15 | 武汉大学 | 一种真菌半乳糖凝集素蛋白活性的多肽、其编码序列及制备方法和应用 |
JP2007131540A (ja) * | 2005-11-08 | 2007-05-31 | Galpharma Co Ltd | Cd44機能抑制因子による抗アレルギー薬、免疫抑制薬および抗腫瘍薬 |
CN102205111B (zh) * | 2011-05-19 | 2013-01-23 | 武汉大学 | 杨树菇半乳糖凝集素在制备抗hiv感染药物中的用途 |
WO2014171018A1 (fr) * | 2013-04-20 | 2014-10-23 | 株式会社ガルファーマ | Procédé permettant de diagnostiquer une maladie (ou des maladies), procédé permettant de traiter ou de prévenir une maladie (ou des maladies), kit permettant de diagnostiquer une maladie (ou des maladies), et médicament permettant de traiter ou de prévenir une maladie (ou des maladies) |
JP5420791B1 (ja) * | 2013-08-23 | 2014-02-19 | 肇 福永 | サルモネラ菌及びシート状m細胞 |
MX2018013683A (es) * | 2016-05-10 | 2019-06-17 | Genentech Inc | Métodos para disminuir los enlaces de trisulfuro durante la producción recombinante de polipéptidos. |
JP7224583B2 (ja) * | 2018-01-29 | 2023-02-20 | 日本メナード化粧品株式会社 | ガレクチン-9産生促進剤 |
CN108409850A (zh) * | 2018-01-30 | 2018-08-17 | 河南师范大学 | 一种鱼源半乳糖凝集素CaGal重组蛋白的制备方法及其应用 |
CN113999287B (zh) * | 2021-12-02 | 2023-06-27 | 深圳湾实验室坪山生物医药研发转化中心 | 一种靶向半乳糖凝集素-10的多肽抑制剂及其制备方法和用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996021671A1 (fr) * | 1995-01-11 | 1996-07-18 | The Trustees Of Columbia University In The City Of New York | Developpement de sondes d'adn et de reactifs immunologiques specifiques de molecules exprimees sur une surface cellulaire et genes associes a la transformation |
WO1996039419A1 (fr) * | 1995-06-06 | 1996-12-12 | Human Genome Sciences, Inc. | Genes et proteines specifiques du colon |
WO1997003190A1 (fr) * | 1995-07-11 | 1997-01-30 | Sagami Chemical Research Center | PROTEINE HUMAINE SEMBLABLE A GALECTINE-4 ET ADNc CODANT CETTE PROTEINE |
-
1997
- 1997-10-09 CA CA002268022A patent/CA2268022A1/fr not_active Abandoned
- 1997-10-09 EP EP97912689A patent/EP1012266A4/fr not_active Withdrawn
- 1997-10-09 WO PCT/US1997/018261 patent/WO1998015624A1/fr not_active Application Discontinuation
- 1997-10-09 JP JP10517750A patent/JP2001501831A/ja not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996021671A1 (fr) * | 1995-01-11 | 1996-07-18 | The Trustees Of Columbia University In The City Of New York | Developpement de sondes d'adn et de reactifs immunologiques specifiques de molecules exprimees sur une surface cellulaire et genes associes a la transformation |
WO1996039419A1 (fr) * | 1995-06-06 | 1996-12-12 | Human Genome Sciences, Inc. | Genes et proteines specifiques du colon |
WO1997003190A1 (fr) * | 1995-07-11 | 1997-01-30 | Sagami Chemical Research Center | PROTEINE HUMAINE SEMBLABLE A GALECTINE-4 ET ADNc CODANT CETTE PROTEINE |
Non-Patent Citations (4)
Title |
---|
HADARI ET AL: "Galectin-8: A new rat lectin, related to Galectin-4", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 270, no. 7, February 1995 (1995-02-01), pages 3447 - 3453, XP002272060 * |
HUFLEJT ET AL.: "Strikingly different localization of Galectin-3 and Galectin-4 in human colon adenocarcinoma T84 cells", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 30, May 1997 (1997-05-01), pages 14294 - 14303, XP002272061 * |
See also references of WO9815624A1 * |
TÜRECI ET AL: "Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 10, March 1997 (1997-03-01), pages 6416 - 6422, XP002272062 * |
Also Published As
Publication number | Publication date |
---|---|
JP2001501831A (ja) | 2001-02-13 |
EP1012266A1 (fr) | 2000-06-28 |
CA2268022A1 (fr) | 1998-04-16 |
WO1998015624A1 (fr) | 1998-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1021185A4 (fr) | Dihydropyrimidines et leurs emplois | |
DE59704951D1 (en) | Plättchenförmiges titandioxidpigment | |
EP1012266A4 (fr) | Galectine 8, 9, 10, et 10sv | |
GB2333453B (en) | Colostrinin and uses thereof | |
EP0894807A4 (fr) | COMPLEXE GPIb-LIPIDE ET SES UTILISATIONS | |
DE59705192D1 (en) | Lcp-blends | |
DE59700372D1 (en) | Blockcopolymere | |
HUP9700446A3 (en) | Oilsuspension-concentrate and using thereof | |
DE59703905D1 (en) | Linearmotorgetriebene transportanlage | |
DE59704086D1 (en) | Twin-dualmode-filter | |
PL331523A1 (en) | Azolotrizines and azolopyrimidines | |
DE59702027D1 (en) | Bragg-modulator | |
DE59705556D1 (en) | Peripheralpumpe | |
HUP9900068A3 (en) | Fuse-switch and/or fuse-disconnector | |
AU131132S (en) | Handleset | |
SG44332A1 (en) | Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas | |
AU131198S (en) | Handleset | |
PL332044A1 (en) | 25-methylene and 24,25-epoxy marcphortines and paraherquamides | |
GB2352176B (en) | Colostrinin and uses thereof | |
DE59610178D1 (en) | Rotationspumpe | |
AU942P (en) | WOORIKEE 2000 Isopogon anemonifolius | |
AU131131S (en) | Handleset | |
AU131199S (en) | Handleset | |
GB9610406D0 (en) | Envirofoam 2000 | |
GB9604269D0 (en) | Poletech 2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19990507 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20040316 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7C 07K 14/47 A |
|
17Q | First examination report despatched |
Effective date: 20040721 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20070503 |